Vicor shares dropped 5.9% after the earnings release, reflecting investor disappointment with the cautious outlook and conservative guidance amid expected licensing timing uncertainty and decelerating export proportion.
Vicor Corporation reported mixed third-quarter results, with a significant revenue decline sequentially primarily due to a prior-period patent settlement, yet maintaining strong year-over-year growth.